LESLIE L. IVERSEN, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ACADIA PHARMACEUTICALS INC

Filing Date Source Excerpt
2009-04-30 Leslie L. Iversen, Ph.D. 71 Chairman of the Board and Director
2010-04-23 Leslie L. Iversen, Ph.D. has been the Chairman of our Board of Directors since December 2000. He has served as a director since 1998. ... The Board of Directors has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. ... The following table shows for the fiscal year ended December 31, 2009 certain information with respect to the compensation of all persons who served as directors of the Company during the year, other than Dr. Hacksell, who is a Named Executive Officer and received no additional compensation for his services as a director: ... Leslie Iversen: Fees Earned or Paid in Cash includes $5,250 in Board of Directors meetings fees and $12,250 of Dr. Iversen’s $32,500 annual retainer paid in cash, which includes $10,000 for serving on the Scientific Advisory Committee of the Board of Directors. Option Awards includes the fair value of 10,000 stock options and 27,777 stock options (from conversion of $20,000 of Dr. Iversen’s $32,500 annual retainer) granted on June 12, 2009 with an exercise price of $2.16. As of December 31, 2009, an aggregate of 139,506 stock options that had been granted to Dr. Iversen as Board compensation were outstanding.
2011-04-25 Leslie L. Iversen, Ph.D. 73 Chairman of the Board and Director ... The following table shows for the fiscal year ended December 31, 2010 certain information with respect to the compensation of all persons who served as directors of the Company during the year, other than Dr. Hacksell, who is a Named Executive Officer and received no additional compensation for his services as a director: Director Compensation for Fiscal 2010 ... Leslie Iversen(6) Fees Earned or Paid in Cash includes $6,000 in Board of Directors and NCG Committee meetings fees. Option Awards includes the fair value of 10,000 stock options and 75,000 stock options (from conversion of a $32,500 annual retainer) each granted on June 11, 2010 with an exercise price of $1.30. As of December 31, 2010, an aggregate of 223,506 stock options that had been granted to Dr. Iversen were outstanding.
2012-04-18 Leslie L. Iversen, Ph.D. has been the Chairman of our Board of Directors since December 2000. He has served as a director since 1998. ... The Board of Directors has an Audit Committee ... Leslie Iversen ... Audit Committee ... Fees Earned or Paid in Cash includes $6,500 in Board of Directors and NCG Committee meetings fees and $20,000 of Dr. Iversen's annual retainer paid in cash. Option Awards includes the total fair value of (i) 10,000 stock options for the annual Board of Directors grant, (ii) 38,571 stock options from the conversion of $22,250 of Dr. Iversen's $42,500 total annual retainer, and (iii) 6,000 stock options for service on the Scientific Advisory Committee of the Board of Directors, each of which was granted on June 10, 2011 with an exercise price of $1.75 per share. Total compensation was $100,105.
2013-04-25 Leslie L. Iversen, Ph.D. has been the Chairman of our Board of Directors since December 2000. He has served as a director since 1998. The Board has an Audit Committee, and Leslie Iversen is a member. Director Compensation for Fiscal 2012 shows Leslie Iversen earned $5,250 in cash and $110,100 in option awards, totaling $115,350.
2014-04-23 Leslie L. Iversen, Ph.D. 76 Chairman of the Board and Director
2015-04-29 Leslie L. Iversen, Ph.D. has been the Chairman of our Board of Directors since December 2000. He has served as a director since 1998. ... The Board has an Audit Committee ... Leslie Iversen Fees Earned or Paid in Cash includes Annual Retainer of $35,000 and Additional Retainer for Board Chair of $22,500. Option Awards includes the fair value of 14,000 stock options granted on June 6, 2014 with an exercise price of $21.99. Total compensation $287,341.
2016-04-29 Leslie L. Iversen, Ph.D. 78 Chairman of the Board and Director

Data sourced from SEC filings. Last updated: 2026-03-14